Point72 Asset Management, L.P. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,418,440
-23.5%
141,500
-30.8%
0.02%
-24.0%
Q2 2023$8,386,532
+144.7%
204,400
+113.2%
0.02%
+127.3%
Q1 2023$3,426,930
+602.2%
95,885
+627.2%
0.01%
+450.0%
Q2 2022$488,000
-70.3%
13,185
-75.6%
0.00%
-71.4%
Q4 2021$1,643,000
-77.7%
53,981
-75.4%
0.01%
-78.1%
Q3 2021$7,355,000
-81.1%
219,300
-77.6%
0.03%
-81.7%
Q2 2021$38,969,000
+71.3%
976,900
+142.8%
0.18%
+57.7%
Q4 2020$22,752,000
+66.2%
402,400
+39.5%
0.11%
+58.6%
Q3 2020$13,689,000
+33.0%
288,492
+65.2%
0.07%
+4.5%
Q2 2020$10,296,000
+3814.8%
174,625
+3033.4%
0.07%
+3250.0%
Q1 2020$263,000
-94.1%
5,573
-93.5%
0.00%
-88.9%
Q3 2018$4,437,000
+249.9%
86,031
+244.1%
0.02%
+200.0%
Q3 2017$1,268,000
-61.2%
25,000
-69.0%
0.01%
-76.0%
Q1 2016$3,264,000
-82.3%
80,600
-72.9%
0.02%
-83.6%
Q4 2015$18,449,000297,9000.15%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders